101Bio - About the company
101Bio is an unfunded company based in Palo Alto (United States), founded in 2013. It operates as a Provider of exosome isolation, protein purification and DNA extraction kits. 101Bio has not raised any funding yet. The company has 1070 active competitors, including 61 funded and 125 that have exited. Its top competitors include companies like Abcam, Meridian Bioscience and Enzo.
Company Details
- Website
- 101bio.com
- Social
- Email ID
- *****@101bio.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2013
Location
Palo Alto, United States
Stage
Unfunded
Ranked
505th among 1070 active competitors
Sign up to download 101Bio's company profile
101Bio's funding and investors
101Bio has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
101Bio's Competitors and alternates
Top competitors of 101Bio include Abcam, Meridian Bioscience and Enzo. Here is the list of Top 10 competitors of 101Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Abcam 1998, Cambridge (United Kingdom), Acquired | Developer of biological reagents for life science research | $78.8M | 76/100 | |
2nd | Meridian Bioscience 1976, Ohio (United States), Acquired | Molecular diagnostic device and kits | - | 65/100 | |
3rd | Enzo 1976, Farmingdale (United States), Acquired | Life science products and services for research, drug discovery, and manufacturing | $7M | - | 65/100 |
4th | Sino Biological 2007, Beijing (China), Series A | Provider of reagents,and kits for clinical research | $29.4M | 63/100 | |
5th | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | $15.5M | 61/100 | ||
6th |  Huwel Life 2015, Hyderabad (India), Series A | Molecular diagnostic solutions and products for the healthcare industry | $5.74M | 59/100 | |
7th | Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised | Develops tools and products for research and clinical application | - | 58/100 | |
8th | Stem Cell Technologies 1993, Vancouver (Canada), Series A | Developer of cell culture media and ancillary reagents for life science research | $11.9M | 58/100 | |
9th |  BioIVT 1981, Westbury (United States), Acquired | Provider of in vitro diagnostic products and assay services | - | 56/100 | |
10th | Cell culture reagents for stem cell research | $18.2M | 56/100 | ||
505th | 101Bio 2013, Palo Alto (United States), Unfunded | Provider of exosome isolation, protein purification and DNA extraction kits | - | - | 24/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on 101Bio's competitors? Click here to see the top ones
101Bio's Investments and acquisitions
101Bio has made no investments or acquisitions yet.
Reports related to 101Bio
Here is the latest report on 101Bio's sector:
Are you a Founder ?
FAQs about 101Bio
Explore our recently published companies
- Longplay - 2026 founded, Unfunded company
- Lala Lajpat Rai College of Commerce and Economics - Mumbai based, 1972 founded, Unfunded company
- Healthcare in - Germany based, Unfunded company
- TYT Studio - Ahmedabad based, 2015 founded, Unfunded company
- Trex Utah - Springville based, Unfunded company
- EPG - Germany based, 1957 founded, Unfunded company
